Hara Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
Hara Capital's BIO Position: Q3 2026 in Review
Hara Capital reduced its Bio-Rad Laboratories Class A (BIO) stake by 10% in Q3 2026, selling an estimated $109K and leaving 2,669 shares worth $1.01M. The position accounts for 0.48% of the portfolio, ranked #50.
Hara Capital first reported a position in BIO in Q3 2025 and has held it in 5 quarters since. 417 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- Hara Capital held 2,669 shares of Bio-Rad Laboratories Class A worth $1.01M as of Q3 2026.
- Hara Capital sold 312 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $109K.
- Bio-Rad Laboratories Class A made up 0.48% of Hara Capital's portfolio in Q3 2026, its #50 holding.
- Hara Capital first reported a position in Bio-Rad Laboratories Class A in Q3 2025 and has held it in 5 quarters since.
- 417 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on Hara Capital's 13F filing for Q3 2026, filed 30 Oct 2026.